These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 15031022)
1. HIV-1 and immune control: can we change the course of HIV-1? Kovacs A; Connors M Lancet; 2004 Mar; 363(9412):833-4. PubMed ID: 15031022 [No Abstract] [Full Text] [Related]
2. HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children. Montesano C; Anselmi A; Palma P; Bernardi S; Cicconi R; Mattei M; Castelli-Gattinara G; Ciccozzi M; Colizzi V; Amicosante M New Microbiol; 2010 Oct; 33(4):303-9. PubMed ID: 21213588 [TBL] [Abstract][Full Text] [Related]
3. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974 [TBL] [Abstract][Full Text] [Related]
4. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434 [TBL] [Abstract][Full Text] [Related]
6. Immune activation and the pathogenesis of HIV disease: implications for therapy. Fernandez S; Lim A; French M J HIV Ther; 2009 Nov; 14(3):52-6. PubMed ID: 20218239 [No Abstract] [Full Text] [Related]
7. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression. Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119 [TBL] [Abstract][Full Text] [Related]
8. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I. Moriuchi H; Moriuchi M Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373 [TBL] [Abstract][Full Text] [Related]
9. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome. Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation. Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652 [TBL] [Abstract][Full Text] [Related]
11. Immunologic features of HIV-1-infected women on HAART at delivery. Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385 [TBL] [Abstract][Full Text] [Related]
12. Do CD8(+)CD25(+) cells predict immune reconstitution syndrome in HIV-positive patients who begin HAART? Cianchetta-Sívori M; Raso S; Fernández-Guerrero M; Górgolas M; García R AIDS; 2007 Nov; 21(17):2347-9. PubMed ID: 18090286 [TBL] [Abstract][Full Text] [Related]
13. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838 [TBL] [Abstract][Full Text] [Related]
14. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation. Benito JM; Lopez M; Lozano S; Ballesteros C; Capa L; Martinez P; Gonzalez-Lahoz J; Soriano V J Infect Dis; 2005 Dec; 192(12):2142-6. PubMed ID: 16288380 [TBL] [Abstract][Full Text] [Related]
15. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence. Sester U; Sester M; Köhler H; Pees HW; Gärtner BC; Wain-Hobson S; Bocharov G; Meyerhans A AIDS Res Hum Retroviruses; 2007 Apr; 23(4):549-53. PubMed ID: 17451343 [TBL] [Abstract][Full Text] [Related]
16. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals. Kolber MA AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy. Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M; Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544 [TBL] [Abstract][Full Text] [Related]
18. Immunologic control of HIV-1. Gandhi RT; Walker BD Annu Rev Med; 2002; 53():149-72. PubMed ID: 11818468 [TBL] [Abstract][Full Text] [Related]
19. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. Sainz T; Serrano-Villar S; Díaz L; González Tomé MI; Gurbindo MD; de José MI; Mellado MJ; Ramos JT; Zamora J; Moreno S; Muñoz-Fernández MA AIDS; 2013 Jun; 27(9):1513-6. PubMed ID: 23435292 [TBL] [Abstract][Full Text] [Related]
20. Elucidating the elite: mechanisms of control in HIV-1 infection. O'Connell KA; Bailey JR; Blankson JN Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]